The 2010 meeting of the editorial board of The American Journal of Cardiology (AJC) was held on March 14, 2010, in Atlanta, Georgia, at the time of the Annual
Scientific Sessions of the American College of Cardiology. The meeting's purpose was
to review the AJC's publication results for 2009, to recognize, in particular, those
AJC board members who had reviewed the most manuscripts in 2009, and to receive criticisms
and suggestions from board members on how to improve the journal. The meeting went
as follows:
- 1Introduction of new editorial board members: these are listed in Table 1Table 1New Board Members in 2009
Jack P. Chen Jean-Pierre Després Allen L. Dollar S. David Gertz Greg L. Kaluza Ellen C. Keeley Lynda E. Rosenfeld - 2AJC board members reviewing the most manuscripts in 2009: their names are listed in Table 2.Table 2Top American Journal of Cardiology board reviewers in 2009
Name No. Reviewed Toby R. Engel 10 Antonio Abbate 9 Ami E. Iskandrian 9 Gregory Y. H. Lip 9 Myrvin H. Ellestad 8 Stephen P. Glasser 8 Monty M. Bodenheimer 8 Carl J. Lavie 8 - 3Numbers of manuscripts submitted, withdrawn, accepted, and refused in 2009: 2,878 manuscripts were received in 2009 (excluding readers' comments); 728 (25%) were accepted, 2,136 (75%) were refused, and 14 (<1%) were withdrawn. The number of manuscripts received in 2009 represented a 1% decrease from the number received in 2008.
- 4Numbers of manuscripts submitted and published or accepted (excluding readers' comments) in the AJC for 1983 to 2009, the period of the present editorship (Table 3): the major reason the acceptance rate was in the mid-20s was that most of the manuscripts published were shortened considerably, allowing space for more reports.Table 3Numbers of manuscripts submitted and published, 1983 to 2009
Year No. of Manuscripts Submitted No. of Manuscripts Published or Accepted Percentage Accepted 1983 1,234 643 52% 1984 1,605 747 46% 1985 1,707 645 38% 1986 1,574 616 39% 1987 1,525 695 46% 1988 1,496 636 42% 1989 1,740 699 40% 1990 1,717 662 38% 1991 1,615 680 42% 1992 1,873 664 35% 1993 1,997 619 31% 1994 1,783 604 34% 1995 1,844 668 36% 1996 1,930 701 36% 1997 1,898 768 40% 1998 1,992 631 31% 1999 2,170 703 32% 2000 2,226 630 28% 2001 2,068 682 33% 2002 2,171 683 31% 2003 2,190 783 36% 2004 2,109 842 39% 2005 2,661 984 37% 2006 3,061 653 21% 2007 3,184 710 22% 2008 2,888 709 25% 2009 2,864 728 25% - 5Sources of manuscripts submitted to the AJC in 2009: of the 1,916 manuscripts submitted from non-United States countries, 341 (18%) were accepted. Of the 948 submitted from the United States, 387 (41%) were accepted.
- 6Numbers of editorial pages, types of reports, and topics of reports published in the AJC in 2009: these are summarized in Table 4. Of the 3,641 editorial pages published in 2009, 3,491 were used for articles and 32 for readers' comments, such that 97% were used for the publication of manuscripts. Of the 632 reports published, 577 (91%) involved multiple patients and 8 (1%), single patients. Twelve reviews, 22 editorials, 5 editor's roundtables and 8 from-the-editor columns were published in 2009. The topics of the articles published in 2009 are also listed in Table 4. Articles having to do with coronary artery disease led the list (45%), and preventive cardiology articles increased to 12%.Table 4Number of editorial pages and types of articles published in the American Journal of Cardiology in 2009 (volumes 103 and 104; nonsymposium issues)
2009, January 1 to December 15, Volumes 103 and 104 Editorial pages Total 3,641 Articles 3,491 (96%) Readers' comments, total, replies 32, 46, 5 (1%) Staff and editorial board 48 Contents 66 Instructions to authors 4 Types of articles 632 Multipatient studies 577 (91%) Case reports 8 (1%) Reviews 12 (2%) Editorials 22 (3%) Editor's roundtable (consensus) 5 (1%) Interviews 0 From-the-editor columns 8 (1%) Topics of articles Total 632 Coronary artery disease 287 (45%) Preventive cardiology 78 (12%) Arrhythmias and conduction disturbances 33 (5%) Heart failure 56 (10%) Valvular heart disease 23 (4%) Cardiomyopathy 32 (5%) Congenital heart disease 34 (5%) Methods 8 (1%) Miscellaneous 61 (10%) Historical studies 2 (<1%) Cardiovascular pharmacology 2 (<1%) Systemic hypertension 8 (1%) Nonpatient studies 8 (1%) - 7Numbers of reports and editorial pages for reports and readers' comments published in the regular issues of the AJC from 1983 to 2009: these are listed in Table 5. These include the 27 full years of the present editorship.Table 5Number of articles and editorial pages for articles and Readers' comments published in 1983 to 2009
Year Pages for Reports Pages for Readers' Comments Total No. of Reports No. of Readers' Comments 1983 3,130 27 3,157 643 53 1984 3,007 36 3,043 747 80 1985 2,623 21 2,644 645 40 1986 2,627 17 2,644 616 40 1987 2,810 23 2,833 695 45 1988 2,646 26 2,672 636 60 1989 2,903 19 2,922 699 36 1990 3,001 20 3,021 662 40 1991 3,165 38 3,203 680 59 1992 3,211 46 3,257 711 53 1993 2,890 37 2,927 650 64 1994 2,493 31 2,524 604 46 1995 2,570 34 2,604 668 52 1996 2,775 29 2,804 658 52 1997 3,328 32 3,360 826 45 1998 3,048 35 3,083 664 37 1999 3,015 38 3,053 680 42 2000 2,962 38 3,000 648 37 2001 3,862 37 3,899 701 39 2002 2,835 45 2,880 680 45 2003 2,982 35 3,017 763 32 2004 3,131 39 3,170 808 42 2005 3,242 43 3,285 736 49 2006 3,406 65 3,471 695 70 2007 3,540 50 3,590 695 59 2008 3,474 48 3,522 647 59 2009 3,491 32 3,523 632 46 - 8Supplements published in the AJC in 2009: these are listed in Table 6. Supplements are published separately from the regular issues, which have blue and white covers and contain advertisements. The supplements, which are underwritten by one or more pharmaceutical or device companies, have white covers and do not contain advertisements.Table 6Supplements published in the 2009 American Journal of Cardiology supplement issues
Topic of Supplement Publication Date Guest Editors No. of Articles No. of Pages Sponsor Antiplatelet therapy February 2 Dominick J. Angiolillo 7 51 Daiichi Sankyo, Eli Lilly Abstracts: Angioplasty Summit TCT Asia Pacific 2009 April 22 128 Cardiovascular Research Foundation Antiplatelet therapy in coronary syndromes and its safety September 7 Steven V. Manoukian 12 63 Sanofi-Aventis Abstracts: transcatheter cardiovascular Sept 21 242 Cardiovascular Research Foundation High-density lipoprotein as a therapeutic target Nov 19 Michael H. Davidson 9 57 Roche Pharmaceuticals Total (n = 5) 28 541 - 9Reviewers of articles published in the AJC in 2009: this supplementary data can be found, in the online version, atdoi:10.1016/j.amjcard.2010.03.054.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
